Investigation
Inari Medical, Inc. (NARI)
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Menu
Investigation
04/29/2022
Initial Lawsuit
07/12/2022
Lawsuit Progression
09/12/2022
A Missfresh Limited (MF) shareholder filed a securities class action lawsuit on behalf of persons who purchased or otherwise, acquired Missfresh securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Missfresh’s June 2021 initial public offering (IPO) and suffered compensable damages caused by the alleged defendants’ violations of the Securities Act of 1933.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors that:
(1) Missfresh provided false financial figures in its registration statement filed with the SEC for its IPO;
(2) Missfresh would need to amend its financial figures;
(3) Missfresh, among other things, had lesser net revenues for the quarter ended March 31, 2021; and
(4) as a result, the defendants’ public statements were materially false and misleading at all relevant times and negligently prepared.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.